S.22 (Act 61)

An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Sponsors: Sen. Virginia Lyons , Sen. Richard McCormack

Last Recorded Action: 5/21/2021 - Senate Message, signed by Governor <strong>June 7, 2021</strong>

Committee Activity - Witnesses Who Testified

Regular Session 2021-2022

House Committee on Health Care
Senate Committee on Health and Welfare